Copyright
©The Author(s) 2021.
World J Clin Cases. Feb 26, 2021; 9(6): 1284-1292
Published online Feb 26, 2021. doi: 10.12998/wjcc.v9.i6.1284
Published online Feb 26, 2021. doi: 10.12998/wjcc.v9.i6.1284
Table 1 Baseline data were compared between the two groups
| Group | n | Year | Sex | Basic diseases | APACHE ІІ | AKI | |||||
| Men | Women | Trauma | Cardiovascular disease | Cerebrovascular disease | Other | ІІ | Ш | ||||
| Alprostadil group | 50 | 61.7 ± 8.0 | 29 | 21 | 13 | 10 | 20 | 7 | 23.6 ± 2.7 | 29 | 21 |
| Control group | 50 | 60.4 ± 10.3 | 32 | 18 | 15 | 6 | 23 | 5 | 24.0 ± 2.5 | 33 | 17 |
| t/χ2 | 0.705 | 0.378 | 1.676 | -0.769 | 0.679 | ||||||
| P | 0.483 | 0.539 | 0.642 | 0.444 | 0.410 | ||||||
- Citation: Jia Y, Liu LL, Su JL, Meng XH, Wang WX, Tian C. Effect of alprostadil in the treatment of intensive care unit patients with acute renal injury. World J Clin Cases 2021; 9(6): 1284-1292
- URL: https://www.wjgnet.com/2307-8960/full/v9/i6/1284.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i6.1284